Nina F Schor
JAMA Neurol . 2025 Mar 1;82(3):211-212. doi: 10.1001/jamaneurol.2024.3954.
This Viewpoint advocates for inclusive artificial intelligence (AI) training and iterative testing and cautions against the uncritical adoption of AI engines that are trained on median patient groups and exclude the outlier groups that neurology regularly treats.